1.65BMarket Cap
LossP/E TTM
AnaptysBio Inc's Company Valuation
Currency: USD Updated: 2026-06-24The current valuation score of AnaptysBio Inc is 9.28, ranking 44 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -57.34, which is -96.24% below the recent high of -2.16 and -165.71% above the recent low of -152.35.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.